Communiqués

25/08/22 SOCL CAP : AUG 2022 - Form 8-K PU
23/08/22 SOCL CAP : Notes To The Condensed Consolidated Financial Statements - Form 8-K PU
19/08/22 AKILI, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
12/08/22 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) AQ
08/07/22 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) AQ
20/05/22 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I Other Events, Financial Statements and Exhibits (form 8-K/A) AQ
20/05/22 Social Capital Suvretta I : REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Form 8-K/A PU
17/05/22 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) AQ
22/04/22 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K) AQ
04/04/22 Akili to Present at Chardan’s Prescription Digital Therapeutics Half-Day Summit BU
24/03/22 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) AQ
17/03/22 Game Industry Veteran Behind Bejeweled, Plants vs. Zombies Joins Akili as Chief Product Officer BU
10/03/22 Akili to Speak at SXSW 2022 on Building a New Class of Disease-Modifying Digital Therapeutics BU
08/03/22 Akili Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022 BU
07/03/22 Akili to Present at Cowen’s 42nd Annual Health Care Conference BU
18/02/22 Akili to Speak on Integrating Digital Therapeutics Into Mainstream Healthcare at DTx West 2022 BU
17/02/22 PLOS ONE Publishes Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning BU
14/02/22 Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I BU
27/01/22 Social Capital Suvretta I : Consolidated Financial Statements - Form 8-K/A PU
27/01/22 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K/A) AQ
27/01/22 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Social Capital Suvretta Holdings Corp. I (Nasdaq - DNAA), Arisz Acquisition Corp. (Nasdaq - ARIZ), Sports Ventures Acquisition Corp. (Nasdaq - AKIC) PR
26/01/22 Social Capital Suvretta I : Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I - Form 8-K PU
26/01/22 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
26/01/22 Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I BU
16/11/21 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K) AQ
Aucun résultat pour cette recherche